Scinai Immunotherapeutics Ltd. SEC filings SCNI

Scinai Immunotherapeutics Ltd. has 495 filings in SEC EDGAR's recent list, going back to Nov 13, 2014. Its latest annual report, Form 20-F, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 15, 2023, covering the quarter ended Mar 31, 2023. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.

Scinai Immunotherapeutics Ltd. SEC filings
Form Description Filed Period
F-3 Shelf registration (foreign issuer) Oct 28, 2026 —
6-K Current report (foreign issuer) Oct 20, 2026 Oct 20, 2026
6-K Current report (foreign issuer) Oct 16, 2026 Oct 16, 2026
6-K Current report (foreign issuer) Oct 15, 2026 Oct 15, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
EFFECT Filing Oct 5, 2026 —
F-1 Registration statement (foreign issuer) Sep 24, 2026 —
6-K Current report (foreign issuer) Sep 21, 2026 Sep 21, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
EFFECT Filing Aug 28, 2026 —
POS AM Post-effective amendment no. 1 to form f-1 Aug 27, 2026 —
6-K Current report (foreign issuer) Aug 26, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 19, 2026 Aug 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 9, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 1, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
6-K Current report (foreign issuer) Jun 17, 2026 Jun 17, 2026
6-K Current report (foreign issuer) Jun 15, 2026 Jun 15, 2026
6-K Current report (foreign issuer) Jun 8, 2026 Jun 8, 2026
EFFECT Filing May 19, 2026 —
424B3 Prospectus May 19, 2026 —
CORRESP Letter to the SEC May 15, 2026 —
UPLOAD Letter from the SEC May 14, 2026 —
6-K Current report (foreign issuer) May 12, 2026 May 12, 2026
F-3 Shelf registration (foreign issuer) May 8, 2026 —
6-K Current report (foreign issuer) May 8, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Apr 27, 2026 Apr 27, 2026
20-F Annual report (foreign issuer) Apr 1, 2026 Dec 31, 2025
3 Initial insider ownership Mar 26, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Mar 23, 2026 Mar 23, 2026
6-K Current report (foreign issuer) Mar 19, 2026 Mar 19, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Feb 25, 2026 Feb 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
6-K Current report (foreign issuer) Feb 17, 2026 Feb 17, 2026
6-K Current report (foreign issuer) Dec 23, 2025 Dec 23, 2025
6-K Current report (foreign issuer) Dec 2, 2025 Dec 2, 2025
6-K Current report (foreign issuer) Nov 13, 2025 Nov 13, 2025
6-K Current report (foreign issuer) Nov 13, 2025 Nov 13, 2025
S-8 Employee stock plan registration Nov 12, 2025 —
6-K Current report (foreign issuer) Oct 6, 2025 Oct 6, 2025
424B3 Prospectus Oct 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 1, 2025 —
EFFECT Filing Sep 30, 2025 —
CORRESP Letter to the SEC Sep 29, 2025 —
UPLOAD Letter from the SEC Sep 29, 2025 —
F-1 Registration statement (foreign issuer) Sep 22, 2025 —
6-K Current report (foreign issuer) Sep 22, 2025 Sep 22, 2025
6-K Current report (foreign issuer) Sep 11, 2025 Sep 11, 2025
EFFECT Filing Sep 8, 2025 —
POS AM Post-effective amendment no. 2 to form f-1 Sep 4, 2025 —
6-K Current report (foreign issuer) Sep 2, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jun 12, 2025 Jun 12, 2025
424B3 Prospectus Jun 5, 2025 —
6-K Current report (foreign issuer) Jun 5, 2025 Jun 5, 2025
6-K Current report (foreign issuer) Jun 2, 2025 Jun 2, 2025
EFFECT Filing May 15, 2025 —
POS AM Post-effective amendment no. 1 to form f-1 May 12, 2025 —
20-F Annual report (foreign issuer) May 7, 2025 Dec 31, 2024
NT 20-F Notification of late filing Apr 29, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 27, 2025 Mar 27, 2025
SCHEDULE 13G Ownership over 5% (passive) Mar 26, 2025 —
6-K Current report (foreign issuer) Mar 24, 2025 Mar 24, 2025
424B3 Prospectus Mar 13, 2025 —
EFFECT Filing Mar 12, 2025 —
CORRESP Letter to the SEC Mar 11, 2025 —
F-1/A Amendment no. 1 to form f-1 Mar 11, 2025 —
UPLOAD Letter from the SEC Mar 11, 2025 —
6-K Current report (foreign issuer) Mar 5, 2025 Mar 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 4, 2025 —
F-1 Registration statement (foreign issuer) Mar 4, 2025 —
6-K Current report (foreign issuer) Mar 4, 2025 Mar 4, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 24, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 24, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 3, 2025 —
6-K Current report (foreign issuer) Nov 25, 2024 Nov 25, 2024
6-K Current report (foreign issuer) Nov 22, 2024 Nov 22, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
6-K Current report (foreign issuer) Oct 15, 2024 Oct 15, 2024
6-K Current report (foreign issuer) Sep 26, 2024 Sep 26, 2024
6-K Current report (foreign issuer) Sep 9, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 29, 2024
6-K Current report (foreign issuer) Aug 21, 2024 Aug 21, 2024
SC 13G/A Amended ownership over 5% (passive) Aug 20, 2024 —
6-K Current report (foreign issuer) Aug 20, 2024 Aug 20, 2024
6-K Current report (foreign issuer) Aug 15, 2024 Aug 15, 2024
6-K Current report (foreign issuer) Aug 13, 2024 Aug 13, 2024
6-K Current report (foreign issuer) Aug 12, 2024 Aug 12, 2024
6-K/A Amendment no.1 to form 6-k Aug 7, 2024 Aug 7, 2024
6-K Current report (foreign issuer) Aug 5, 2024 Aug 5, 2024
6-K Current report (foreign issuer) Jul 15, 2024 Jul 15, 2024
6-K Current report (foreign issuer) Jul 15, 2024 Jul 15, 2024
6-K Current report (foreign issuer) Jul 8, 2024 Jul 8, 2024
6-K Current report (foreign issuer) Jul 8, 2024 Jul 8, 2024
6-K Current report (foreign issuer) Jul 8, 2024 Jul 8, 2024
6-K Current report (foreign issuer) Jun 14, 2024 Jun 14, 2024
6-K Current report (foreign issuer) Jun 13, 2024 Jun 13, 2024
6-K Current report (foreign issuer) Jun 13, 2024 Jun 13, 2024
6-K Current report (foreign issuer) May 28, 2024 May 28, 2024
424B3 Prospectus May 16, 2024 —
6-K Current report (foreign issuer) May 15, 2024 May 15, 2024
20-F Annual report (foreign issuer) May 15, 2024 Dec 31, 2023
6-K Current report (foreign issuer) May 7, 2024 May 7, 2024
NT 20-F Notification of late filing Apr 30, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
6-K Current report (foreign issuer) Apr 16, 2024 Apr 16, 2024
SC 13D Ownership over 5% (active) Mar 12, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
EFFECT Filing Feb 13, 2024 —
CORRESP Letter to the SEC Feb 9, 2024 —
UPLOAD Letter from the SEC Feb 2, 2024 —
F-3 Shelf registration (foreign issuer) Jan 30, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 24, 2024 —
6-K Current report (foreign issuer) Jan 18, 2024 Jan 18, 2024
D Filing Jan 12, 2024 —
6-K Current report (foreign issuer) Jan 9, 2024 Jan 9, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Jan 4, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 2, 2024 —
424B3 Prospectus Jan 2, 2024 —
424B3 Prospectus Jan 2, 2024 —
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
424B3 Prospectus Jan 2, 2024 —
EFFECT Filing Dec 26, 2023 —
CORRESP Letter to the SEC Dec 26, 2023 —
F-1/A Amendment no. 1 to form f-1 Dec 22, 2023 —
6-K Current report (foreign issuer) Dec 14, 2023 Dec 14, 2023
6-K Current report (foreign issuer) Nov 20, 2023 Nov 20, 2023
6-K Current report (foreign issuer) Nov 13, 2023 Nov 13, 2023
6-K Current report (foreign issuer) Nov 7, 2023 Nov 7, 2023
6-K Current report (foreign issuer) Nov 3, 2023 Nov 3, 2023
6-K Current report (foreign issuer) Nov 2, 2023 Nov 2, 2023
F-1 Registration statement (foreign issuer) Oct 30, 2023 —
D Filing Oct 3, 2023 —
6-K Current report (foreign issuer) Sep 22, 2023 Sep 22, 2023
6-K Current report (foreign issuer) Sep 20, 2023 Sep 20, 2023
6-K Current report (foreign issuer) Sep 19, 2023 Sep 19, 2023
424B5 Prospectus supplement Sep 19, 2023 —
6-K Current report (foreign issuer) Sep 11, 2023 Sep 11, 2023
424B3 Prospectus Sep 7, 2023 —
6-K Current report (foreign issuer) Sep 6, 2023 Sep 6, 2023
6-K Current report (foreign issuer) Sep 6, 2023 Sep 6, 2023
424B2 Prospectus Aug 28, 2023 —
EFFECT Filing Aug 25, 2023 —
6-K Current report (foreign issuer) Aug 24, 2023 Aug 24, 2023
CORRESP Letter to the SEC Aug 23, 2023 —
6-K Current report (foreign issuer) Aug 23, 2023 Aug 23, 2023
UPLOAD Letter from the SEC Aug 22, 2023 —
F-3 Shelf registration (foreign issuer) Aug 18, 2023 —
6-K/A Amendment no. 2 to form 6-k Aug 18, 2023 Jun 30, 2023
6-K/A Amendment no. 1 to form 6-k Aug 14, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 11, 2023 Aug 11, 2023
6-K Current report (foreign issuer) Aug 1, 2023 Aug 1, 2023
6-K Current report (foreign issuer) Jul 12, 2023 Jul 12, 2023
6-K Current report (foreign issuer) Jul 5, 2023 Jul 5, 2023
6-K Current report (foreign issuer) Jul 5, 2023 Jul 5, 2023
6-K Current report (foreign issuer) Jul 3, 2023 Jul 3, 2023
6-K Current report (foreign issuer) Jul 3, 2023 Jul 3, 2023
8-K Current report
Material agreement
Jun 8, 2023 Jun 4, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Officer or director change
May 11, 2023 May 10, 2023
8-K Current report
Listing notice
May 4, 2023 May 1, 2023
8-K Current report
Regulation FD disclosure
May 4, 2023 May 4, 2023
S-8 Employee stock plan registration Apr 17, 2023 —
10-K Annual report Apr 17, 2023 Dec 31, 2022
NT 10-K Notification of late filing Apr 3, 2023 Dec 31, 2022
SC 13G/A Amended ownership over 5% (passive) Feb 6, 2023 —
6-K Current report (foreign issuer) Jan 23, 2023 Jan 23, 2023
3/A Filing Jan 23, 2023 Jan 1, 2023
3/A Filing Jan 23, 2023 Jan 1, 2023
3/A Filing Jan 23, 2023 Jan 1, 2023
3/A Filing Jan 23, 2023 Jan 1, 2023
6-K Current report (foreign issuer) Jan 11, 2023 Jan 11, 2023
6-K Current report (foreign issuer) Jan 9, 2023 Jan 9, 2023
3 Initial insider ownership Jan 5, 2023 Jan 1, 2023
6-K Current report (foreign issuer) Jan 4, 2023 Jan 4, 2023
SC 13G Ownership over 5% (passive) Jan 4, 2023 —
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
3 Initial insider ownership Jan 3, 2023 Jan 1, 2023
6-K Current report (foreign issuer) Dec 29, 2022 Dec 29, 2022
SC 13D/A Amended ownership over 5% (active) Dec 27, 2022 —
6-K Current report (foreign issuer) Dec 20, 2022 Dec 20, 2022
424B4 Prospectus Dec 20, 2022 —
6-K Current report (foreign issuer) Dec 19, 2022 Dec 19, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
SCNI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Jerusalem, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1611747
Former names
BiondVax Pharmaceuticals Ltd. (until Aug 28, 2023)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.